Who are the key players in the insulin delivery devices market?

Some key players operating in the insulin delivery devices market include Medtronic, Novo Nordisk A/S, Sanofi, Eli Lilly and Company, Ypsomed AG, Insulet Corporation, B. Braun SE, Owen Mumford Ltd., BD (Becton, Dickinson and Company), and Tandem Diabetes Care, Inc.

What are the factors driving the insulin delivery devices market?

Key factors driving the insulin delivery devices market include the increasing prevalence of diabetes worldwide, advancements in insulin administration technology, growing awareness among patients about the benefits of automated insulin delivery devices over traditional syringe methods, and the convenience and ease of use offered by them.

How big is the insulin delivery devices market?

The global insulin delivery devices market size was estimated at USD 19.3 billion in 2025 and is expected to reach USD 20.9 billion in 2026.

What is the insulin delivery devices market growth?

The global insulin delivery devices market is expected to grow at a compound annual growth rate of 7.8% from 2026 to 2033 to reach USD 35.2 billion by 2033.

Which segment accounted for the largest insulin delivery devices market share?

The insulin pens segment dominated the insulin delivery devices market with the highest share in 2025. This is attributable to the increasing prevalence of diabetes, their superior convenience, ease of use, and dosing accuracy compared to traditional vial-and-syringe methods, making them highly suitable for daily self-administration.